CELL AND GENE THERAPY INSIGHTS

March 2026 Issue

Volume 12 Issue 2

Cell and Gene Therapy Insights Volume 12 Issue 2
Download PDF

Featuring

Issue Spotlight: Gene therapy analytics/CMC
Supply Chain focus: Raw and Starting Materials
Vectors focus: Upstream Processing 2026
Other articles
Webinars

SPOTLIGHT

Gene therapy analytics/CMC
Srivatsan Ramesh
Guest Editor:
Srivatsan Ramesh, Scientist at BridgeBio

Foreword

Engineering confidence in the next era of AAV-based gene therapy

Engineering confidence in the next era of AAV-based gene therapy

Srivatsan Ramesh
27 March
Read

Research Article

Tailored analytical strategies for AAV aggregation: purpose‑driven method selection for enhanced product development

Tailored analytical strategies for AAV aggregation: purpose‑driven method selection for enhanced product development

Y Zhao, L Wang, J S Reeves et al.
31 March
Read

Expert Insight

New analytical method for rAAV titer and empty/full ratio determination in cell lysate and conditioned medium

New analytical method for rAAV titer and empty/full ratio determination in cell lysate and conditioned medium

Yuki Yamaguchi, Susumu Uchiyama
31 March
Read

Viewpoint

Unraveling the analytical bottlenecks in AAV characterization: the transformative promise of NGS

Unraveling the analytical bottlenecks in AAV characterization: the transformative promise of NGS

Prateek Tripathi
6 March
Read
From dose quantity to dose quality: elevating rAAV genome integrity as a CMC attribute

From dose quantity to dose quality: elevating rAAV genome integrity as a CMC attribute

XuShan Wang, Sarah M Richer, Beverly A Heinz
3 March
Read
Next-generation strategies for managing AAV pre-existing immunity: beyond standard companion diagnostics

Next-generation strategies for managing AAV pre-existing immunity: beyond standard companion diagnostics

Katherine Block
24 February
Read

Supply Chain FOCUS

Raw and Starting Materials

Viewpoint

Building confidence in cell and gene therapy: USP’s role in an evolving therapeutic frontier

Building confidence in cell and gene therapy: USP’s role in an evolving therapeutic frontier

Fouad Atouf
17 March
Read

Vectors FOCUS

Upstream Processing 2026

Interview

Advancing AAV manufacturing through platform design and process understanding

Advancing AAV manufacturing through platform design and process understanding

Pranav Joshi
31 March
Read

articles

Editorial

Editor’s picks: exploring in vivo cell and gene therapies

Editor’s picks: exploring in vivo cell and gene therapies

Abigail Pinchbeck
16 March
Read

Innovator Insight

Choosing a biomanufacturing service organization: from the BSO perspective

Choosing a biomanufacturing service organization: from the BSO perspective

R Thevi Guntnur, R Rendon III, J Higdon et al.
26 March
Read

Industry Insights

Industry Insights: Regulatory dynamics and clinical progress in early 2026

Industry Insights: Regulatory dynamics and clinical progress in early 2026

Abigail Pinchbeck
8 April
Read

Webinars

}